SCP Scope Fluidics S.A.

33.61USD135.20 PLN · GPW-1.89%Mkt Cap: 106.49M USDP/E: —

Scope Fluidics S.A., a biotechnology company, designs and develops projects based on microfluidic technologies in medical diagnostics and healthcare in Poland. It offers BacterOMIC, an antibiotic susceptibility testing. …

Key Statistics

Company
Market Cap106.49M USD
Enterprise Value77.41M USD
Revenue (TTM)-128.53K USD
Gross Profit-904.43K USD
Net Income (TTM)-11.53M USD
Revenue/Share-0.04 USD
Last Price33.61 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees175
CountryPL
SectorHealthcare
IndustryDiagnostics & Research
ISINPLSCPFL00018
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.78
EV/Revenue-602.29
P/S-828.53
P/B3.09
EPS (TTM)-4.23 USD
EPS (Forward)—
52W Range
27.1036% of range45.30
52W High45.30 USD
52W Low27.10 USD
Profitability
Gross Margin-3638.00%
Oper. Margin10633.46%
EBITDA Margin0.00%
Profit Margin-46364.00%
ROE-28.54%
ROA-23.66%
ROIC-617.66%
ROCE-25.81%
Growth
Revenue Growth-95.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.46M USD
CapEx (TTM)3.33M USD
FCF Margin9590.26%
FCF Yield-11.58%
Net Debt-29.08M USD
Net Debt/EBITDA2.17
Net Debt/FCF—
Balance Sheet
Debt/Equity0.01
Current Ratio10.52
Quick Ratio9.88
Book Value/Sh10.89 USD
Cash/Share9.36 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMar 24, 2023
Pay Date—
Analyst Consensus
Rating—
Target (Mean)55.66 USD
Upside (mean)+65.6%
Target Range55.66 USD – 55.66 USD
# Analysts1
Ownership
Shares Out.3.17M
Float2.34M
Insiders22.85%
Institutions21.74%
Technical
SMA 5033.17 (+1.3%)
SMA 20032.87 (+2.2%)
Beta-0.09
S&P 52W Chg12.00%
Avg Vol (30d)3.43K
Avg Vol (10d)2.14K
Technical Indicators
RSI (14)48.1
MACD3.0812
MACD Signal4.2814
MACD Hist.-1.2002
BB Upper39.89 USD
BB Middle34.47 USD
BB Lower29.06 USD
BB Width31.41%
ATR (14)1.833 USD
Vol Ratio (20d)0.67x

About Scope Fluidics (WSE: SCP)

›

Scope Fluidics (WSE: SCP) is listed on Warsaw Stock Exchange, where its shares trade in PLN. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 175 employees.

The shares were at 135.20 PLN on 19 November 2026, down 13.2% over 52 weeks. Its 52-week range is 109.00 PLN to 182.20 PLN: the price is 25.8% below the high and 24.0% above the low.

Its market capitalisation is 428.35M PLN.

Scope Fluidics reports return on equity of -28.5% and revenue down 95.1% year over year.

It holds more cash than debt, a net cash position of 116.96M PLN. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. One analyst covers the stock; their mean price target of 223.90 PLN is 65.6% above the current price.